CN103143000B - 一种重组人干扰素α2b制剂 - Google Patents
一种重组人干扰素α2b制剂 Download PDFInfo
- Publication number
- CN103143000B CN103143000B CN201310073573.2A CN201310073573A CN103143000B CN 103143000 B CN103143000 B CN 103143000B CN 201310073573 A CN201310073573 A CN 201310073573A CN 103143000 B CN103143000 B CN 103143000B
- Authority
- CN
- China
- Prior art keywords
- preparation
- recombinant human
- human interferon
- interferon alpha
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310073573.2A CN103143000B (zh) | 2013-03-07 | 2013-03-07 | 一种重组人干扰素α2b制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310073573.2A CN103143000B (zh) | 2013-03-07 | 2013-03-07 | 一种重组人干扰素α2b制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103143000A CN103143000A (zh) | 2013-06-12 |
CN103143000B true CN103143000B (zh) | 2014-11-05 |
Family
ID=48541509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310073573.2A Active CN103143000B (zh) | 2013-03-07 | 2013-03-07 | 一种重组人干扰素α2b制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103143000B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109010803A (zh) * | 2018-10-26 | 2018-12-18 | 安徽安科生物工程(集团)股份有限公司 | 一种重组人干扰素α2b滴眼液及其制备方法 |
CN109602705A (zh) * | 2018-12-26 | 2019-04-12 | 安徽安科生物工程(集团)股份有限公司 | 一种重组人干扰素α2b喷雾剂 |
CN113797318B (zh) * | 2021-10-26 | 2023-06-30 | 深圳科兴药业有限公司 | 一种干扰素组合物及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1245434A (zh) * | 1996-12-24 | 2000-02-23 | 拜奥根有限公司 | 稳定的液体干扰素制剂 |
CN101780033A (zh) * | 2009-12-21 | 2010-07-21 | 北京凯因科技股份有限公司 | 一种预充式重组人干扰素注射剂 |
CN101843896A (zh) * | 2009-03-27 | 2010-09-29 | 长春海伯尔生物技术有限责任公司 | 高浓度低装量重组人干扰素α2b注射液 |
-
2013
- 2013-03-07 CN CN201310073573.2A patent/CN103143000B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1245434A (zh) * | 1996-12-24 | 2000-02-23 | 拜奥根有限公司 | 稳定的液体干扰素制剂 |
CN101843896A (zh) * | 2009-03-27 | 2010-09-29 | 长春海伯尔生物技术有限责任公司 | 高浓度低装量重组人干扰素α2b注射液 |
CN101780033A (zh) * | 2009-12-21 | 2010-07-21 | 北京凯因科技股份有限公司 | 一种预充式重组人干扰素注射剂 |
Also Published As
Publication number | Publication date |
---|---|
CN103143000A (zh) | 2013-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103209966B (zh) | 6-氟-3-羟基-2-吡嗪甲酰胺的钠盐 | |
EP1958643B1 (en) | Stable formulations containing enhancing proportions of gamma- and alpha-interferons | |
CN103143000B (zh) | 一种重组人干扰素α2b制剂 | |
CN101439180A (zh) | 一种提高乌司他丁稳定性的药物组合物 | |
RU2014124171A (ru) | Лекарственное средство для терапевтического лечения и/или улучшения состояния при сепсисе | |
CN101439181B (zh) | 一种稳定的乌司他丁水针剂药物组合物 | |
CN102813632A (zh) | 一种稳定的胸腺法新制剂及其制备方法 | |
CN101317846B (zh) | 一种用于戒毒、镇痛的河豚毒素制剂 | |
CN101234193B (zh) | 含有重组人血清白蛋白融合干扰素的稳定水溶液 | |
JP2010503665A (ja) | 経口剤の形状でインスリンを作製する方法 | |
CN103432569A (zh) | 重组人血清白蛋白-干扰素α融合蛋白的水溶液及其制备方法 | |
CN102697703B (zh) | 一种吡罗昔康凝胶制剂及其制备方法 | |
US3876774A (en) | Method of using a simple protein derived from liver | |
CN101703466A (zh) | 冰片注射剂及其制剂方法 | |
JPS62153224A (ja) | プラスミノゲン製剤 | |
TW201004656A (en) | A stable fluid composition of taxane derivatives, preparing method and use thereof | |
CN105796487B (zh) | 一种米力农注射液及其制备方法 | |
JPS59181223A (ja) | インタ−フエロンの安定化法 | |
CN103690560A (zh) | 一种转化糖电解质注射液药物组合物及其制备方法 | |
CN104173278A (zh) | 一种基于Brij97液晶的皮下注射给药系统及其制备方法 | |
CN103585119A (zh) | 一种包含依前列醇及其药用盐的稳定化制剂及其制备方法 | |
CN101851604A (zh) | 一种人血白蛋白的生产方法 | |
CN102210646B (zh) | 一种人用狂犬病疫苗凝胶剂及其制备方法 | |
CN103006537A (zh) | 一种用于治疗银屑病的凝胶制剂及其制备方法 | |
CN102335126A (zh) | 奥硝唑注射液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Recombinant human interferon alpha2b preparation Effective date of registration: 20161101 Granted publication date: 20141105 Pledgee: Huizhou Merchants Bank Hefei Mengcheng road subbranch Pledgor: Anhui Anke Biotechnology (Group) Co., Ltd. Registration number: 2016990000929 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210209 Granted publication date: 20141105 Pledgee: Huizhou Merchants Bank Hefei Mengcheng road subbranch Pledgor: ANHUI ANKE BIOTECHNOLOGY (Group) Co.,Ltd. Registration number: 2016990000929 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |